High-demand antifungal and antibacterial APIs compliant with Health Products Regulatory Authority (HPRA) and European Pharmacopoeia (Ph. Eur.) standards.
A comprehensive examination of supply chain integration, regulatory compliance, and China Industry 4.0 synergy for Irish CDMOs and formulators.
Ireland has established itself as an undeniable global nexus for biopharmaceutical manufacturing and life science innovation. Hosting 9 of the top 10 global pharmaceutical giants, key clusters across Dublin, Cork (Ringaskiddy), and Shannon generate over €106 billion in annual exports. However, as the industry pivots aggressively toward complex biotherapeutics, target-specific peptide synthetics, and niche oncology active ingredients, the demand for robust, high-purity Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates has hit an unprecedented peak.
Irish Finished Dosage Form (FDF) manufacturers and contract development and manufacturing organizations (CDMOs) operate under the stringent oversight of the Health Products Regulatory Authority (HPRA) and the European Medicines Agency (EMA). Maintaining absolute supply reliability while adhering to strict EU-GMP, cGMP, and ICH Q7 guidelines requires strategic API sourcing partners capable of delivering verified raw materials backed by comprehensive CEP (Certificate of Suitability) and US FDA DMF documentation.
In recent years, global supply chain disruptions have underscored the vital need for multi-regional procurement models. China's transformation through Industry 4.0 Smart Manufacturing in the chemical and pharmaceutical sector presents Irish drug manufacturers with unprecedented structural advantages:
Gentolex bridge China's massive smart-factory API synthesis capability directly with Ireland's rigorous pharmaceutical manufacturing requirements.
Complete ASMF, DMF, CEP, and EDQM documentation provided for HPRA submission.
From non-natural amino acids to modified lipopeptides and complex GLP-1 sequences.
Gentolex provides end-to-end support for Irish biopharmaceutical enterprises, from early stage R&D custom synthesis to full commercial-scale FDF licensing.
An overall factory construction area of 250,000 square meters under international standards to offer flexible, scalable, and cost-effective solutions for chemical intermediates and fine chemicals.
Gentolex offers an extensive range of APIs and intermediates for development study and commercial application with cGMP standard from long-term collaborations. Full documentation (DMF, CEP) supported worldwide.
Specialized focus on complex peptide sequences, novel amino acid derivative fragments, and specialized solid-phase/liquid-phase synthesis tailored to therapeutic clinical pipelines.
For clients seeking to streamline vendor oversight, we offer customized procurement services across superior global supply chains, taking care of logistics, audits, and regulatory filings.
High-purity therapeutic active ingredients, metabolic regulators, hair growth peptides, and GLP-1 peptide building blocks available for direct export to Ireland.
Gentolex’s overarching goal is to create seamless strategic opportunities connecting global healthcare formulation leaders with guaranteed pharmaceutical raw materials and advanced custom synthesis services. To date, Gentolex Group proudly serves life science clients across more than 10 countries, supported by dedicated representative entities established in key global markets including Mexico and South Africa.
Our operational framework focuses specifically on supplying high-purity peptide APIs, novel amino acid derivatives, target-specific small molecule APIs, FDF (Finished Dosage Form) license-out agreements, technical consultation, facility setup, and integrated global supply chain logistics.
Explore our recent research technical updates on novel therapeutic peptides and high-purity API active raw materials.
Selank Acetate API is a synthetic heptapeptide active pharmaceutical ingredient composed of Thr-Lys-Pro-Arg-Pro-Gly-Pro sequence derived from endogenous immunomodulatory peptides.
Read Whitepaper
Trusted Thymosin Beta-4 API manufacturer delivering high-purity Tβ4 solutions engineered specifically for therapeutic cell repair research and clinical pipeline formulations.
Read Whitepaper
Synthetic pentadecapeptide active ingredient with structural stability, engineered for gastrointestinal tissue protection, tissue repair, and inflammatory pathway research.
Read Whitepaper
Synthetic peptide derived from an ACTH fragment. Highly studied for neuroactive research applications with ultra-pure HPLC validation and stable lyophilization.
Read Whitepaper
SS-31 API (Elamipretide, MTP-131) is a synthetic mitochondria-targeting tetrapeptide designed to bind cardiolipin in the inner mitochondrial membrane to support cellular bioenergetics.
Read WhitepaperKey information for Quality Assurance Directors, Procurement Managers, and Regulatory Specialists in Irish biopharmaceutical companies.
Yes. All primary APIs supplied by Gentolex to the Irish market come with full regulatory support packages. Depending on the molecule, we provide Drug Master Files (DMF), ASMF (Active Substance Master File), and Certificates of Suitability (CEP) issued by the EDQM, ensuring seamless authorization during HPRA (Health Products Regulatory Authority) registration.
For standard stocked APIs and commercial batches, air freight delivery directly to Dublin Airport (DUB) or Cork Airport (ORK) typically requires 5 to 7 business days under validated temperature-controlled cold chain conditions. For custom peptide synthesis, lead times range between 3 to 6 weeks based on sequence complexity and scale.
Every API batch undergoes rigorous testing including High-Performance Liquid Chromatography (HPLC), Mass Spectrometry (LC-MS), Karl Fischer water determination, residual solvent analysis via GC, and bacterial endotoxin testing (LAL test). Certificates of Analysis (COA) specifying exact purity levels (often >99.5%) are included with every dispatch.
Absolutely. We specialize in high-purity complex side-chain protected amino acids and peptide fragments (such as Ste-γ-Glu-AEEA-AEEA-OSU and Boc-His(Trt)-Aib-Glu(OtBu)-Gly-OH) specifically optimized for modern metabolic therapeutic production lines, available in multi-kilogram commercial batches.
Contact our specialized technical sales team to request Certificates of Analysis (COAs), regulatory DMF packages, audit schedules, or customized project quotations.